These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6915133)

  • 21. Clinical biochemical and haemodynamic correlates of sodium sensitivity in essential hypertension.
    Koolen MI; Bussemaker-Verduyn den Boer E; van Brummelen P
    J Hypertens Suppl; 1983 Dec; 1(2):21-3. PubMed ID: 6400114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary kallikrein excretion is low in malignant essential hypertension.
    Hilme E; Herlitz H; Gyzander E; Hansson L
    J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary kallikrein in normal and hypertensive pregnancies.
    Elebute OA; Mills IH
    Perspect Nephrol Hypertens; 1976; 5():329-38. PubMed ID: 1005045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of dietary sodium in hypertension not treated with drugs].
    Krzesinski JM; Du F; Pequeux ML; Rorive G
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1201-4. PubMed ID: 1336357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension.
    Bragulat E; de la Sierra A; Antonio MT; Jiménez W; Urbano-Márquez A ; Coca A
    Clin Sci (Lond); 2001 Jul; 101(1):73-8. PubMed ID: 11410117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Krück F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():263s-265s. PubMed ID: 261517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinations of urinary kallikrein and urinary kininase excretion in human hypertension.
    Greco AV; Porcelli G
    Panminerva Med; 1985; 27(3):119-24. PubMed ID: 3853777
    [No Abstract]   [Full Text] [Related]  

  • 29. An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
    Kamata Y; Fujita T; Kato T; Hayashi I; Kurosaka M; Katori M; Fujita Y; Majima M
    Hypertens Res; 2009 Mar; 32(3):220-6. PubMed ID: 19262486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prepuberal gonadectomy upon aldosterone levels in female and male SHR: interaction between blood pressure and kallikrein kinin system.
    Oddo EM; de Luca Sarobe V; Krmar R; Periz GA; Herrera H; Martín RS; Ibarra FR; Arrizurieta EE
    Clin Exp Hypertens; 2006 Feb; 28(2):157-70. PubMed ID: 16546841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for environmental familiality of kallikrein excretion in Utah kindreds.
    Dadone MM; Smith JB; Anderton DL; Ash KO; Williams RR
    West J Med; 1986 May; 144(5):559-63. PubMed ID: 3636040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of salt loading on urinary excretion of kallikrein in normotensive subjects and patients with essential hypertension].
    Igari T
    Nihon Naika Gakkai Zasshi; 1984 Aug; 73(8):1149-57. PubMed ID: 6569066
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of aldosterone and adrenocorticotropic hormone on urinary kallikrein excretion.
    Nagashima Y; Honda M; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1269-76. PubMed ID: 3029483
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary kallikrein excretion in normotensive and spontaneously hypertensive rats.
    Arrigoni-Martelli E; Nielsen CK
    Acta Pharmacol Toxicol (Copenh); 1975 Aug; 37(2):177-84. PubMed ID: 1173732
    [No Abstract]   [Full Text] [Related]  

  • 35. [A clinical study on urinary kallikrein in patients with renal diseases (author's transl)].
    Numahata H
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):203-17. PubMed ID: 470231
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary kallikrein excretion in children of parents with essential hypertension.
    Uchiyama M; Otsuka T; Sakai K
    Arch Dis Child; 1985 Oct; 60(10):974-5. PubMed ID: 3851647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary kallikrein in hypertension and renovascular hypertension].
    Chernova NA; Nekrasova AA
    Kardiologiia; 1971; 11(4):84-9. PubMed ID: 5096587
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of aging on urinary kallikreins and other vasoactive substances in essential hypertension.
    Fang S; Abe K; Omata K; Yasujima M; Yoshinaga K
    Adv Exp Med Biol; 1989; 247B():139-44. PubMed ID: 2692411
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary kallikrein and urinary prostaglandin E2 in genetically hypertensive mice.
    Sustarsic DL; McPartland RP; Rapp JP; Schlager G; Tan SY
    Proc Soc Exp Biol Med; 1980 Feb; 163(2):193-9. PubMed ID: 6899337
    [No Abstract]   [Full Text] [Related]  

  • 40. [CME. Hypertension and salt intake: salt-free for all?].
    Zechmann S; Suter PM
    Praxis (Bern 1994); 2014 Jun; 103(12):679-86. PubMed ID: 24894610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.